Lawson, a globally respected investor advisor, encourages Reata Pharmaceuticals, Inc. loss-making investors to obtain legal counsel’s support before the important deadline for securities class actions – RETA – QNT Press Release


New York, January 8, 2022 (Global News Agency)- Why: Rosen Law Firm, a global investor rights law firm, reminds buyers to pay attention to Reata Pharmaceuticals, Inc. (Nasdaq stock code:straight) From November 9, 2020 to December 8, 2021 (both inclusive) (“Course Period”), important February 18, 2022 Deadline for the lead plaintiff.

So: If you purchased Reata Pharmaceuticals securities during the class action, you may be entitled to compensation without having to pay any out-of-pocket expenses or expenses incurred through contingency fee arrangements.

What to do next: To join the Reata Pharmaceuticals class action, please visit http://www.rosenlegal.com/cases-register-2230.html Or call Phillip Kim, Esq.Toll free 866-767-3653 or email [email protected] or [email protected] Information about class actions. A class action has been filed.If you want to be the lead plaintiff, you must move the court No later than February 18, 2022The lead plaintiff is the representative party who directs the litigation on behalf of other class members.

Why choose Rosen method: We encourage investors to choose qualified lawyers with a successful record of leadership…

The full story can be found on Benzinga.com



Source link

Recommended For You

About the Author: News Center